How did Compumedics fare in the first half of FY21?

• January 19, 2021 03:18 PM AEDT
• Hina Chowdhary

A data-baked drug development firm, Emyria Limited (ASX:EMD) witnessed an impressive growth of 7.407% (A$0.145) at AEDT 2:57 PM in its shares post the release of its quarterly activities report for the quarter ended 31 December 2021. The Company l...

• January 19, 2021 01:03 PM AEDT
• Kunal Sawhney

Summary Creso Pharma has received a repeat purchase order for its animal health products range, anibidiol® valued at A$247,826 from Virbac Switzerland. The new purchase order adds to the strong demand for its products across Europe, Latin A...

• January 19, 2021 12:05 PM AEDT
• Kunal Sawhney

Summary Medibio Limited disclosed that its sleep staging software, MEBsleep, has obtained CE Mark approval. With the CE Mark, the health technology player can accelerate MEBsleep commercialisation activities in the EEC. The Company is investig...

• January 19, 2021 10:52 AM AEDT
• Kunal Sawhney

Summary Factor Therapeutics has called off LONGMILE deal due to prolonged transaction process and changes in business circumstances. Net cash at the end of December 2020 quarter was reported at A$3.19 million. Factor Therapeutics’ share ...

• January 18, 2021 06:08 PM AEDT
• Team Kalkine

Summary Chimeric Therapeutics commenced trading on the ASX today following the successful completion of its IPO. The drug development company raised almost A$35 million from Institutional as well as sophisticated investors. The Company would u...

• January 18, 2021 01:55 PM AEDT
• Team Kalkine

Australian medical device company PolyNovo Limited (ASX:PNV) has recently released an update on its business performance. In its interim trading update, the company has reported an increase of 31% in sales for H1 FY21 when compared with t...

• January 16, 2021 03:24 AM AEDT
• Kunal Sawhney

Summary The healthcare sector, considered a defensive one, witnessed an unprecedented rise in demand for healthcare products and services due to the COVID-19 pandemic. Starpharma to launch its COVID-19 spray VIRALEZE™ during the first qua...

• January 14, 2021 02:43 PM AEDT
• Team Kalkine

Summary Innovative Australian company Nanollose has applied a patent for a superior tenacity lyocell fibre with Grasim Industries. The joint patent will provide the two companies additional IP as well as a premium fibre. Following the patent f...

• January 14, 2021 12:21 PM AEDT
• Kunal Sawhney

Summary ASX-200 medical imaging player Pro Medicus enters in an agreement with Intermountain Healthcare to implement Visage 7 technology. The Intermountain deal represents the fifth major contract secured by Pro Medicus in the last six months. ...

• January 14, 2021 10:53 AM AEDT
• Kunal Sawhney

On 14 January 2021, Orthocell Limited (ASX:OCC) has announced that it has been granted FDA 510(k) clearance to go ahead with its CelGro collagen medical device's supply and marketing. The company plans to use the device in the procedures related to...